Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | DGKA | P23743 | 1/20 | 0.30 |
| ▸ | BCL9 | O00512 | 1/20 | 0.30 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL21352286 | 0.94 | ALDH1A1 (0.60) | ALDH1A1CES2CES1HDAC3HDAC1 | |
| SCHEMBL118947 | 0.88 | ALDH1A1 (0.50) | ALDH1A1TSHRNAAA | |
| SCHEMBL6526444 | 0.87 | ALDH1A1 (0.50) | ALDH1A1CES2CES1TSHRLMNA | |
| SCHEMBL29000361 | 0.86 | ALDH1A1 (0.67) | ALDH1A1CES2CES1HDAC3HDAC1 | |
| SCHEMBL10640242 | 0.85 | ALDH1A1 (0.94) | ALDH1A1CES2CES1HDAC3HDAC1 | |
| SCHEMBL6535867 | 0.85 | DGKA (0.48) | ALDH1A1CES2CES1TSHRLMNA | |
| SCHEMBL28139327 | 0.84 | ALDH1A1 (0.58) | ALDH1A1CES2CES1LMNANAAA | |
| SCHEMBL10949517 | 0.84 | DGKA (0.52) | ALDH1A1CES2CES1TSHRLMNA | |
| SCHEMBL6889455 | 0.84 | DGKA (0.52) | ALDH1A1CES2CES1TSHRLMNA | |
| SCHEMBL9565427 | 0.84 | DGKA (0.52) | ALDH1A1CES2CES1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2018 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689898-B1 | LONG-ACTING CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) DERIVATIVE | HANMI PHARMACEUTICAL CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| US-12508298-B2 | Protein complex by use of a specific site of an immunoglobulin fragment for linkage | HANMI PHARM. CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| US-20250222078-A1 | MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS | HALOZYME, INC. (US) | 2025-07-10 | — | — | US | claimed |
| EP-4580694-A1 | SEALANTS FOR TISSUE CLOSURE | Ethicon, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| CN-120131925-A | Pegylated phenylalanine lyase injection and application thereof | 重庆派金生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119816334-A | Sealant for tissue closure | 爱惜康股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-4534107-A2 | PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE | Hanmi Pharm. Co., Ltd. (KR) | 2025-04-09 | — | — | EP | claimed |
| CN-119780422-A | Alkaline phosphatase antibody marker, preparation method thereof, detection reagent and kit | 深圳市锦瑞生物科技股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-118649280-B | Highly stable biological glue matrix and preparation method thereof | 卓阮医疗科技（苏州）有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-115721730-B | Pegylated vascular endothelial inhibin analogue and application thereof | 北京普罗吉生物科技发展有限公司 | 2025-03-14 | — | — | CN | claimed |
| WO-2004089345-A1 | BONE TARGETING OF BIODEGRADABLE DRUG-CONTAINING NANOPARTICLES | SEMAFORE PHARMACEUTICALS INC. (US) | 2004-10-21 | — | — | WO | claimed |
| US-6774180-B2 | FOR CONJUGATION WITH BIOLOGICALLY ACTIVE AGENT IS SELECTED FROM A PROTEIN, PEPTIDE, CARBOHYDRATE, OLIGONUCLEOTIDE, DNA, RNA, AND LIPID | NEKTAR THERAPEUTICS AL, CORPORATION | 2004-08-10 | — | — | US | claimed |
| EP-1355676-A2 | PROTECTING THERAPEUTIC COMPOSITIONS FROM HOST-MEDIATED INACTIVATION | University of South Carolina Research Foundation (US) | 2003-10-29 | — | — | EP | claimed |
| EP-1355936-A2 | POLYMER CONJUGATES OF NEUBLASTIN AND METHODS OF USING SAME | BIOGEN, INC. (US) | 2003-10-29 | — | — | EP | claimed |
| EP-1345982-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT NON-PEPTIDIC POLYMER DERIVATIVES | Nektar Therapeutics Al, Corporation (US) | 2003-09-24 | — | — | EP | claimed |
| WO-2002060929-A2 | POLYMER CONJUGATES OF NEUBLASTIN AND METHODS OF USING SAME | BIOGEN, INC. (US) | 2002-08-08 | — | — | WO | claimed |
| WO-2002059179-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT NON-PEPTIDIC POLYMER DERIVATIVES | SHEARWATER CORPORATION (US) | 2002-08-01 | — | — | WO | claimed |
| US-20020082345-A1 | Synthesis of high molecular weight non-peptidic polymer derivatives | SHEARWATER CORPORATION | 2002-06-27 | — | — | US | claimed |
| US-20020065397-A1 | Protecting therapeutic compositions from host-mediated inactivation | UNIVERSITY OF SOUTH CAROLINA | 2002-05-30 | — | — | US | claimed |
| WO-2002031498-A2 | PROTECTING THERAPEUTIC COMPOSITIONS FROM HOST-MEDIATED INACTIVATION | UNIVERSITY OF SOUTH CAROLINA (US) | 2002-04-18 | — | — | WO | claimed |